Pay in 4 interest-free payments of $6.00 Learn more
Ships within 48 hours · Estimated delivery Aug 21 - Aug 26
Senescent Chondrocyte Removal & Chondrogenic Potential Restoration (PMC, 2021) FOXO4-DRI Removes Replication-Stress Senescent Chondrocytes in ACI Research Model A study published in PMC investigated FOXO4-DRI in the context of autologous chondrocyte implantation (ACI) a procedure in which in vitro chondrocyte expansion generates a senescent cell burden that adversely affects cartilage formation quality and quantity
[18] FDA identified limitations in characterization data, potential immunogenicity concerns for injectable use, limited information for proposed routes, lack of established effectiveness for obesity, and insufficient long-term safety information
This dramatic evidence gap defines the current landscape and shapes how we should interpret both the promising preclinical data and the abundant anecdotal reports
In addition, the peptide has shown significant effects in DNA regulation, infectious diseases, and even some types of cancer and tumorigenesis
10.3389/fimmu.2022.866379 Front Immunol
